Brookline, MA, United States of America

Moses J Folkman

This inventor holds 31 USPTO granted patents. Top assignees: Children's Medical Center Corporation, Takeda Chemical Industries, Inc., Harvard College. Active years: 1979-2008.


% Patents Active = 74.2

Average Co-Inventor Count = 2.3

ph-index = 15

Forward Citations = 1,071(Granted Patents)


Company Filing History:


Years Active: 1979-2008

Loading Chart...
Areas of Expertise:
Estrogenic Compounds
Anti-Mitotic Agents
Angiogenesis
Tumor Treatment
Smooth Muscle Mitogen
FGF Composition
Angiogenesis Inhibitors
Controlled Release Systems
Ulcerating Diseases
O-Substituted Fumagillol
Growth Inhibiting Agents
Heparin Assay
31 patents (USPTO):Explore Patents

Title: The Legacy of Moses J. Folkman: Pioneering Innovations in Medicine

Introduction: Moses J. Folkman, a distinguished inventor hailing from Brookline, MA, made significant contributions to the field of medicine through his groundbreaking innovations.

Latest Patents: Moses J. Folkman held several patents related to medical advancements, including novel drug delivery systems and innovative surgical techniques.

Career Highlights: Throughout his illustrious career, Folkman revolutionized the medical world with his pioneering research on angiogenesis, the process of new blood vessel formation. His work laid the foundation for new cancer treatments and therapies for various diseases.

Collaborations: Folkman collaborated with leading medical institutions, pharmaceutical companies, and research centers worldwide to further his research and bring his innovative ideas to life. His collaborative efforts led to the development of life-saving treatments that have impacted countless lives.

Conclusion: Moses J. Folkman's legacy as an inventor and medical pioneer continues to inspire future generations to push the boundaries of innovation in the pursuit of improving healthcare and saving lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…